Recruiting Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) NCT06144606 Conditions Acute Lymphoblastic Leukemia, B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, +20 more Locations Moffitt Cancer Center — Tampa, Florida, United States View Trial Details
Recruiting A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab NCT07422337 Conditions B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia, B-Cell Lymphoblastic Leukemia, +26 more Locations Arkansas Children's — Little Rock, Arkansas, United States Arkansas Children's Northwest — Springdale, Arkansas, United States View Trial Details
Recruiting Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia NCT06607419 Conditions B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more Locations Anhui Provincial Children's Hospital — Hefei, Anhui, China Fujian Children's Hospital — Fuzhou, Fujian, China Shanghai Children's Medical center — Shanghai, Shanghai Municipality, China Ningbo Women and Children's Hospital — Ningbo, Zhejiang, China View Trial Details
